AiCuris Overview

  • Founded
  • 2006
  • Status
  • Private
  • Employees
  • 50
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $36.6M
Latest Deal Amount
  • Investors
  • 8

AiCuris General Information


Operator of a medical research agency intended to offer novel antiviral and antibacterial agents. The company's agency engages in discovery, research and development of antiviral and antibacterial agents to treat severe and potentially life-threatening infectious diseases, enabling physicians to offer effective health outcomes to their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • P.O. Box 10 17 09
  • 42017 Wuppertal
  • Germany
+49 0202 00000

AiCuris Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AiCuris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 31-Jan-2018 $36.6M 000.00 Completed Clinical Trials - Phase 2
4. Grant 01-Nov-2017 00000 000.00 Completed Generating Revenue
3. Later Stage VC 000.00 Completed Clinical Trials - Phase 2
2. Corporate 23-Apr-2010 $74.8M $74.8M Completed Startup
1. Angel (individual) 01-Mar-2006 Completed Startup
To view AiCuris’s complete valuation and funding history, request access »

AiCuris Executive Team (3)

Name Title Board Seat Contact Info
Holger Zimmermann Chief Executive Officer & Managing Director
Holger Schmoll Chief Financial Officer & Managing Director
Helga Rubsamen-Schaeff Ph.D Founder & Chairman, Scientific Advisory Board
To view AiCuris’s complete executive team members history, request access »

AiCuris Board Members (1)

Name Representing Role Since
Helga Rubsamen-Schaeff Ph.D Self Founder & Chairman, Scientific Advisory Board 000 0000
To view AiCuris’s complete board members history, request access »

AiCuris Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AiCuris Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Commission Government 000 0000 000000 0
U.S. Food and Drug Administration Government 000 0000 000000 0
Bayer Pharma Corporation Minority 000 0000 000000 0
Thomas Strüngmann Angel (individual) Minority 000 0000 000000 0
DOM Capital Group Family Office Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »